Prof. Lieping Chen

陈列平 教授

免疫学家，肿瘤学家

美国耶鲁大学UTC癌症研究讲席教授，免疫学、肿瘤内科学和皮肤病学教授

耶鲁癌症中心免疫学部主任

首先克隆B7-H1(PD-L1)并阐明其免疫抑制作用

首次证明抗体阻PD1/PD-L1通路可用于肿瘤免疫治疗，并发起和组织全球首个临床试验 2014 年 William B. Coley Award

2016年 美国免疫学会Steinman Award

2017 年 Warren Alpert Foundation Prize

2018年“独墅湖杯”最具影响力药物研发领军人物奖 2020年 国际免疫治疗协会Richard V. Smalley Award

 英文：

Immunologist, oncologist

Chair Professor of Cancer Research, Yale University UTC, Professor of Immunology, Medical Oncology and Dermatology

Director of Immunology Department at Yale Cancer Center

First clone B7-H1 (PD-L1) and clarify its immunosuppressive effect

Demonstrated for the first time that antibodies blocking the PD1/PD-L1 pathway can be used for tumor immunotherapy, and initiated and organized the world's first clinical trial 2014 William B. Coley Award

2016 Steinman Award of American Society of Immunology

2017 Warren Alpert Foundation Prize

2018 "Dushu Lake Cup" Most Influential Drug Development Leader Award 2020 International Immunotherapy Association Richard V. Smalley Award